首页> 外文期刊>Ultrasound in Medicine and Biology >NEUROPROTECTIVE EFFECT OF LOW-INTENSITY PULSED ULTRASOUND AGAINST MPP+-INDUCED NEUROTOXICITY IN PC12 CELLS: INVOLVEMENT OF K2P CHANNELS AND STRETCH-ACTIVATED ION CHANNELS
【24h】

NEUROPROTECTIVE EFFECT OF LOW-INTENSITY PULSED ULTRASOUND AGAINST MPP+-INDUCED NEUROTOXICITY IN PC12 CELLS: INVOLVEMENT OF K2P CHANNELS AND STRETCH-ACTIVATED ION CHANNELS

机译:低强度脉冲超声对PC12细胞MPP +诱导神经毒性的神经保护作用:K2P通道的累积和拉伸活化离子通道

获取原文
获取原文并翻译 | 示例
           

摘要

Parkinson's disease is the second most common neurodegenerative disease. It is characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta. 1-Methyl-4-phenylpyridinium (MPP+) is a dopaminergic neuronal toxin that is widely used in constructing Parkinson's disease models in vitro. Low-intensity pulsed ultrasound (LIPUS) is a non-invasive therapeutic approach that has neuromodulation and neuroprotective effects in the central neural system; however, whether LIPUS can provide protection for dopaminergic neurons against MPP+-induced neurocytotoxicity remains unknown. In this study, we found that pre-treatment with LIPUS (1 MHz, 50 mW/cm(2), 20% duty cycle and 100-Hz pulse repetition frequency, 10 min) inhibited MPP+-induced neurotoxicity and mitochondrial dysfunction in PC12 cells. LIPUS decreased MPP+-induced oxidative stress by modulating antioxidant proteins, including thioredoxin-1 and heme oxygenase-1, and prevented neurocytotoxicity via the phosphoinositide 3-kinase (PI3K)-Akt and ERK1/2 pathways. Furthermore, these beneficial effects were attributed to the activation of K2P channels and stretch-activated ion channels by LIPUS. These data indicate that LIPUS protects neuronal cells from MPP+-induced cell death through the K2P channel-and stretch-activated ion channel-mediated downstream pathways. The data also suggest that LIPUS could be a promising therapeutic method in halting or retarding the degeneration of dopaminergic neurons in Parkinson's disease in a non-invasive manner. (C) 2017 World Federation for Ultrasound in Medicine & Biology.
机译:帕金森的疾病是第二种最常见的神经变性疾病。它的特征在于,在Implia nigra Pars ComparaA中失去多巴胺能神经元。 1-甲基-4-苯基吡啶(MPP +)是一种多巴胺能神经元毒素,广泛用于在体外构建帕金森病模型。低强度脉冲超声(Lipus)是一种非侵入性治疗方法,具有中枢神经系统中的神经调节和神经保护作用;然而,脂肪是否可以为MPP +诱导的神经细胞毒性提供对多巴胺能神经元的保护仍然未知。在这项研究中,我们发现用脂肪治疗(1MHz,50mW / cm(2),20%占空比和100-Hz脉冲重复频率,10分钟)抑制MPP +诱导的PC12细胞中的神经毒性和线粒体功能障碍。通过调节抗氧化蛋白,包括硫辛-1和血红素氧酶-1,并通过磷酸阳性3-激酶(PI3K)-AKT和ERK1 / 2途径防止神经细胞毒性,通过调节抗氧化蛋白(包括硫酸辛蛋白),降低MPP +诱导氧化胁迫。此外,这些有益效果归因于唇膏激活K2P通道和拉伸活化离子通道。这些数据表明,脂肪通过K2P通道和拉伸活化离子通道介导的下游途径保护来自MPP +诱导的细胞死亡的神经元细胞。数据还表明,唇膏可以是在不侵入的方式中停止或延迟帕金森病中多巴胺能神经元的退化的有希望的治疗方法。 (c)2017年中国医学与生物学中超声波的世界联合会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号